MARINA DOLMATOVA: Open Payments
NPI 1043865421 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 33 payments from 8 companies in 2025. Trend: 2023 $2,703 · 2024 $3,358 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $233 |
| Janssen Biotech, Inc. | 10 | $164 |
| UCB, Inc. | 2 | $54 |
| Lilly USA, LLC | 2 | $37 |
| Organon LLC | 3 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: TREMFYA, SKYRIZI, RINVOQ, Bimzelx, TALTZ, SPEVIGO, Otezla, COSENTYX.
Industry payments across WA — which companies pay providers there.
